Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
44
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (30 ops.)
€10.6M

Latest filing published 07 Mar 2025 for Madrigal Pharmaceuticals, INC., €565k.

Filing timeline

BuySale
Robert E. Waltermire

Insider track record

Disclosed buys
0
Disclosed sells
30
Signal history

Robert E. Waltermire: trading record in brief

Robert E. Waltermire appears in our data through filings on Madrigal Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 44 filings; the first trade dates from 16 January 2023 and the latest from 5 March 2025.

No open-market purchase appears, only 30 sales worth €10.6M. Other entries cover 4 share grants and 10 option exercises. So far in 2025, the count stands at no purchases and 13 sales.

The record was last updated on 7 March 2025 with a share grant in Madrigal Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert E. Waltermire

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations